|Bid||0.0000 x 0|
|Ask||0.0000 x 0|
|Day's Range||0.0752 - 0.0790|
|52 Week Range||0.0165 - 0.2100|
|Beta (5Y Monthly)||-11.41|
|PE Ratio (TTM)||N/A|
|Earnings Date||Nov 24, 2020|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||N/A|
(OTC Pink: TREP) Trucept Inc. has retained RBSM LLP to fully audit its financial records, with plans to uplist its publicly traded stock to the OTCQB. This move gives the company stock the advantage of being quoted by dealers.
Trucept Inc. (OTC Pink: TREP) Trucept Inc. ("Trucept") recently filed its third quarter financial results for the calendar year 2020. The company reported income of $3,124,071 for the three months ended September 30th, 2020 compared to $2,092,567 during the same period in 2019.
Trucept Inc. (OTC Pink: TREP) Trucept Inc. ("Trucept") has released its updated financials for Q2 2020. The company has experienced five consecutive quarters of profitability and projects $400 million in annual payroll processing in 2020 with 40 percent gross profit equating to $8.4 million (25 percent net profit equating to $5.8 million, respectively). Additionally, Trucept reported revenues of $4.9 million in June (an increase from $2,295,165 in Q1) and a gross profit of $2,884,115 (an increase from $1,334,266 in Q1).